GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition - Archive ouverte HAL Access content directly
Journal Articles Therapeutic Advances in Chronic Disease Year : 2020

GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition

(1, 2) , , (1, 2) , , , , (3) , , , , , , , , , , , ,
1
2
3
Zuzana Macek Jilkova
Marie Novello
Keerthi Kurma
  • Function : Author
Seyedeh Tayebeh Ahmad Pour
  • Function : Author
Lise Vanderlynden
  • Function : Author
Lionel Fizanne
  • Function : Author
Firas Bassissi
  • Function : Author
Madani Rachid
  • Function : Author
Jennifer Tracz
  • Function : Author
Jérôme Boursier
  • Function : Author
Jérôme Courcambeck
  • Function : Author
Cindy Serdjebi
  • Function : Author
Christelle Ansaldi
  • Function : Author
Thomas Decaens
Philippe Halfon
  • Function : Author
Sonia Brun

Dates and versions

hal-02977880 , version 1 (26-10-2020)

Identifiers

Cite

Eloïne Bestion, Zuzana Macek Jilkova, Jean-Louis Mège, Marie Novello, Keerthi Kurma, et al.. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Therapeutic Advances in Chronic Disease, 2020, 11, pp.204062232094204. ⟨10.1177/2040622320942042⟩. ⟨hal-02977880⟩
22 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More